Obstetrics & Gynecology Hospital Of Fudan University
Clinical trials sponsored by Obstetrics & Gynecology Hospital Of Fudan University, explained in plain language.
-
Immune cell combo shows promise for Hard-to-Treat gynecologic cancers
Disease control Recruiting nowThis early-phase study tests a new treatment that combines specially grown immune cells (tumor-specific T cells) with standard immunotherapy for people with advanced gynecologic cancers like ovarian, cervical, or endometrial cancer. The goal is to see if the combination is safe a…
Phase: EARLY_PHASE1 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated May 17, 2026 08:19 UTC
-
New hope for tough ovarian cancers: Triple-Drug attack enters testing
Disease control Recruiting nowThis study is testing whether a combination of three drugs can help control recurrent ovarian cancer. It will involve about 20 adults whose cancer has returned after initial treatment. The main goals are to see if the treatment shrinks tumors and to understand what side effects p…
Phase: PHASE2 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Massive study aims to predict cancer risk after molar pregnancy
Knowledge-focused Recruiting nowThis study follows nearly 1,500 people who have had a hydatidiform mole (a rare pregnancy complication) to learn how often it turns into cancer and why. Researchers will track health outcomes and use the data to create better diagnosis and treatment guidelines. Participants must …
Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC